SCHEMBL23787582

SCHEMBL23787582

CCc1cc(-c2cc(CC)c(/N=N/c3c(S(=O)(=O)O)cc4ccccc4c3N)c(CC)c2)cc(CC)c1/N=N/c1c(S(=O)(=O)O)cc2ccccc2c1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 3/20 0.42
▸ MPL P40238 6/20 0.41
▸ CTRC Q99895 2/20 0.41
▸ SUMO2 P61956 4/20 0.41
▸ SUMO1 P63165 4/20 0.41
▸ SENP7 Q9BQF6 4/20 0.41
▸ SENP2 Q9HC62 4/20 0.41
▸ SENP1 Q9P0U3 4/20 0.41
▸ SENP3 Q9H4L4 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ APP P05067 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ SNCA P37840 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23787548 0.88 ENPP2 (0.48) ENPP2MPLCTRCSUMO2SUMO1
SCHEMBL23787644 0.86 CYP1A2 (0.47) ENPP2MPLCTRCALDH1A1MEN1
SCHEMBL23787637 0.85 ENPP2 (0.48) ENPP2MPLCTRCSUMO2SUMO1
SCHEMBL23787694 0.83 SENP2 (0.50) ENPP2MPLSUMO2SUMO1SENP7
SCHEMBL23787730 0.83 ENPP2 (0.46) ENPP2MPLCTRCSUMO2SUMO1
SCHEMBL23787695 0.82 ENPP2 (0.44) ENPP2MPLCTRCSUMO2SUMO1
SCHEMBL23787733 0.82 ENPP2 (0.44) ENPP2MPLCTRCSUMO2SUMO1
SCHEMBL23787533 0.82 SENP2 (0.40) ENPP2MPLCTRCSUMO2SUMO1
SCHEMBL23787617 0.81 SENP2 (0.64) ENPP2MPLCTRCSUMO2SUMO1
SCHEMBL23787683 0.81 SENP2 (0.51) ENPP2MPLCTRCSUMO2SUMO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) 2021-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF POLG, POLB, POLA1 ENPP2 2691/4885MPL 2115/4885CTRC 3691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback